Abstract
547 Background: AR expression is a favorable prognostic factor in estrogen receptor (ER) positive and ER negative breast cancer. Here we explore the association between AR, Ki67, and the 21-gene recurrence score (RS). We hypothesized that ER-positive breast cancers with high AR expression will be associated with a low Ki67 and RS. Methods: Sequential patients with lymph node negative, ER positive and HER2 negative breast cancer who had surgery at Mount Sinai Hospital, Toronto between January 2010 and October 2013 and in whom the RS was requested were identified. Archival tissue was sectioned and stained for AR (AR441 clone, Dako) and Ki67 (MIB-1 clone, Dako) and then visualized by protein polymer (MACH4, Biocare) and DAB chromogen. AR was scored using the Allred system and Ki67 by manual count (using the Ki67 working group recommendations) by a single pathologist. Associations between RS and AR, age, grade, mitotic score, Ki67, and the extent of ER and progesterone receptor (PgR) expression were assessed ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
